| Hamid Sami, MD, MSC | |
|
455 Lewis Ave Ste 202, Meriden, CT 06451-2124 | |
| (203) 630-1000 | |
| (203) 413-3333 |
| Full Name | Hamid Sami |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 30 Years |
| Location | 455 Lewis Ave Ste 202, Meriden, Connecticut |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750327482 | NPI | - | NPPES |
| 001422899 | Medicaid | CT |
| Facility Name | Location | Facility Type |
|---|---|---|
| Midstate Medical Center | Meriden, CT | Hospital |
| Entity Name | Connecticut Neurological Specialist, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750468963 PECOS PAC ID: 1850390428 Enrollment ID: O20061208000055 |
News Archive
Patients with anaplastic lymphoma kinase-rearranged non-small-cell lung cancer who have leptomeningeal metastases may benefit from treatment with the second-generation ALK inhibitor alectinib, a case series suggests.
Here's a hypothetical scenario: You're the president. You've just botched the roll out of what should have been your signature accomplishment, a major reform of the health insurance system. The public's hopping mad because you said anyone who liked his insurance plan would be able to keep it, but that wasn't true. So what do you do now? What the actual president did was suggest we all discuss health insurance with their families this holiday season (Andrew Rosenthal, 11/20).
Warner Chilcott Limited has announced hat one of its subsidiaries and Mayne Pharma International Pty. Ltd. ("Mayne") have filed a second lawsuit against Impax Laboratories, Inc. ("Impax") in the District Court for the District of New Jersey for infringement of Mayne's U.S. Patent No. 6,958,161 (the "'161 Patent") which covers DORYX, a tetracycline-class oral antibiotic.
Most postmenopausal women with small breast tumors don't need chemotherapy to reduce their recurrence risk after lumpectomy.
A nationally representative survey conducted in the U.S. suggests that the public is fairly evenly divided in its support of immunity certificates or "passports" to enable the selective lifting of restrictions placed on people during the COVID-19 pandemic.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hamid Sami, MD, MSC 455 Lewis Ave Ste 202, Meriden, CT 06451-2124 Ph: (203) 630-1000 | Hamid Sami, MD, MSC 455 Lewis Ave Ste 202, Meriden, CT 06451-2124 Ph: (203) 630-1000 |
News Archive
Patients with anaplastic lymphoma kinase-rearranged non-small-cell lung cancer who have leptomeningeal metastases may benefit from treatment with the second-generation ALK inhibitor alectinib, a case series suggests.
Here's a hypothetical scenario: You're the president. You've just botched the roll out of what should have been your signature accomplishment, a major reform of the health insurance system. The public's hopping mad because you said anyone who liked his insurance plan would be able to keep it, but that wasn't true. So what do you do now? What the actual president did was suggest we all discuss health insurance with their families this holiday season (Andrew Rosenthal, 11/20).
Warner Chilcott Limited has announced hat one of its subsidiaries and Mayne Pharma International Pty. Ltd. ("Mayne") have filed a second lawsuit against Impax Laboratories, Inc. ("Impax") in the District Court for the District of New Jersey for infringement of Mayne's U.S. Patent No. 6,958,161 (the "'161 Patent") which covers DORYX, a tetracycline-class oral antibiotic.
Most postmenopausal women with small breast tumors don't need chemotherapy to reduce their recurrence risk after lumpectomy.
A nationally representative survey conducted in the U.S. suggests that the public is fairly evenly divided in its support of immunity certificates or "passports" to enable the selective lifting of restrictions placed on people during the COVID-19 pandemic.
› Verified 7 days ago
Daniela Lares, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 134 State St, Meriden, CT 06450 Phone: 203-237-2229 Fax: 203-686-1677 | |
Dr. Faye Jones Heisler, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 271 Finch Ave, Meriden, CT 06451 Phone: 203-237-8084 Fax: 203-639-1333 | |
Harold E Trinkoff, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 816 Broad Street, Suite 28, Meriden, CT 06450 Phone: 203-237-8115 Fax: 203-634-8102 | |
Dr. Jonathan Craig Allen, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 883 Paddock Ave, Meriden, CT 06450 Phone: 203-630-5368 | |
Dr. Steven Kahn, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 391 Broad St, Meriden, CT 06450 Phone: 203-237-0002 Fax: 203-639-1976 | |
Dr. Joanna Jakubowska, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 271 Finch Ave, Meriden, CT 06451 Phone: 203-237-8084 Fax: 203-639-1333 |